(Q53260055)

12 May 2018

title

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. (English)

1 reference

12 May 2018

1 reference

Haruhiko Akiyama

1

1 reference

12 May 2018

Patrick L McGeer

series ordinal

2

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

12 May 2018

published in

Nature Medicine

1 reference

12 May 2018

volume

10

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

117-8; author reply 118-9

1 reference

12 May 2018

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Phagocytosis of ?/A4 amyloid fibrils of the neuritic neocortical plaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein.

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Inflammation, autotoxicity and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Is there a future for vaccination as a treatment for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Brain microglia constitutively express beta-2 integrins

1 reference

https://api.crossref.org/works/10.1038%2FNM0204-117

7 January 2021

Identifiers

DOI

10.1038/NM0204-117

1 reference

12 May 2018

1 reference

12 May 2018